跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG
Approved
STANDARD
NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
4070d9801e714407
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
4070d9801e714407
Drug Cima Aemps Name
NINTEDANIB STADA 150 MG CÁPSULAS BLANDAS EFG
Register Number
89299
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2024-02-13
Dosage Form
CÁPSULA BLANDA
Dose
150 mg
Route Of Administration
VÍA ORAL
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Laboratorio Stada S.L.
Active Ingredients
NINTEDANIB ESILATO
180,6 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
4070d9801e714407
Type
Standard
Back to CIMA-AEMPS Approvals
